Photo Gallery

Login

Search

News & Updation

  • Updated Version
  • WJPPS introducing updated version of OSTS (online submission and tracking system), which have dedicated control panel for both author and reviewer. Using this control panel author can submit manuscript
  • Call for Paper
    • WJPPS  Invited to submit your valuable manuscripts for Coming Issue.
  • Journal web site support Internet Explorer, Google Chrome, Mozilla Firefox, Opera, Saffari for easy download of article without any trouble.
  •  
  • WJPPS Impact Factor
  • Its our Pleasure to Inform you that WJPPS Impact Factor has been increased from  7.454 to 7.632  due to high quality Publication at International Level

  • ICV
  • WJPPS Rank with Index Copernicus Value 84.65 due to high reputation at International Level

  • WJPPS APRIL ISSUE PUBLISHED
  • APRIL 2021 Issue has been successfully launched on 1 April 2021.

Abstract

CLINICAL STUDY OF ROLE OF AMLAKI AND GAIRIK CHURNA IN AMLAPITTA

*Dr. Anil Raghunath Wagh, Dr. Ravindra Aniruddha Mirgane, Dr. Nitin Chudaman Jadhav and Dr. Roshan Shankar Dhale

ABSTRACT

Amlapitta is described as special disease in Ayurveda, it is also described as acidity in modern medical science. Increase in the ushna, tikshana gunas in the body,due to apthya ahara and vihara is cosetive factor of amlapitta. Amlaki, Guna- Laghu, Ruksha, Shita. Rasa- Shadrasa exept lavan rasa but amla ras pradhana. Madhura rasa and shita virya are pittashamak. Gairik is khanija dravya, it is a special type of soil, hard in constitution, like a soft rock. Shuddha Gairik, Rasa- Madhura, Kashaya, Virya – shita Hence noth amalaki churna and gairik churna were used in amlapitta vyadhi Dose- 1 gm Amlaki churna + 125 mg Gairik churna was used in TDS Dose. ANUPANA- Honey (Madhu) was used as anupana. It was also usefull for mixing of both churnas.it was also useful for better taste, good compliance of patients as well as good result. Total 50 patients were treated of which 29 were female and 21 were male. 17 female (58%), and 13 male (62%) patients showed best relief. Total 60% 10 female (47%), and 4 male (19%), showed better relief from amlapitta. Total 28%. While 2 female (5%), and 4 male (19%), patients showed minimum or no relief from amlapitta. Total 12%.

Keywords: Amlapitta, Aamalaki, Gairik, Madhu.


[Full Text Article]

Call for Paper

World Journal of Pharmacy and Pharmaceutical Sciences (WJPPS)
Read More

Online Submission

World Journal of Pharmacy and Pharmaceutical Sciences (WJPPS)
Read More

Email & SMS Alert

World Journal of Pharmacy and Pharmaceutical Sciences (WJPPS)
Read More